The Patent Finder

Kolinpharma S.P.A.

7 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Aug 2035
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Nov 28, 2026
    The maintenance fee for Composition for the treatment and prevention of urinary tract infections (US 10,300,099) comes due Nov 28, 2026. Unpaid by May 28, 2027, it lapses early.
  • 1 fee due Mar 17, 2027
    The maintenance fee for Composition for the treatment of neuropathies and/or neuropathic pain (US 10,413,526) comes due Mar 17, 2027. Unpaid by Sep 17, 2027, it lapses early.
  • 1 fee due Aug 4, 2027
    The maintenance fee for Composition for the treatment of arthropathies and osteoarthritis (US 10,548,937) comes due Aug 4, 2027. Unpaid by Feb 4, 2028, it lapses early.
  • 1 fee due Sep 10, 2027
    The maintenance fee for Composition having a muscle-relaxant and anti-inflammatory activity (US 10,583,120) comes due Sep 10, 2027. Unpaid by Mar 10, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 7 of 7

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,548,937Composition for the treatment of arthropathies and osteoarthritis
In force
 · USPTO record
In forceUSPTO record
US 10,583,120Composition having a muscle-relaxant and anti-inflammatory activity
In force
 · USPTO record
In forceUSPTO record
US 11,090,287Composition for the prevention and treatment of metabolic disorders associated with menopause and climacteric
In force
 · USPTO record
In forceUSPTO record
US 9,980,940Composition for the treatment of neuropathies and/or neuropathic pain
In force
 · USPTO record
In forceUSPTO record
US 10,300,099Composition for the treatment and prevention of urinary tract infections
In force
 · USPTO record
In forceUSPTO record
US 10,413,526Composition for the treatment of neuropathies and/or neuropathic pain
In force
 · USPTO record
In forceUSPTO record
US 12,329,724Composition based on L-tryptophan, resveratrol and crocus sativus extract for the treatment of menstrual cycle disorders
In force
 · USPTO record
In forceUSPTO record

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

4 no status recorded

Showing 1 to 4 of 4, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. No title is shown: the bulk publication record carries none for these applications, and this site holds no USPTO file history for them.

ApplicationFiledStatus
18/032,779Nov 16, 2021No status recorded
17/785,004Dec 18, 2020No status recorded
16/635,364Aug 2, 2018No status recorded
15/964,371Apr 27, 2018No status recorded
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited